Literature DB >> 6100881

A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide, and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension.

D G Vidt.   

Abstract

Enalapril and enalapril/hydrochlorothiazide are effective in treating mild to moderate essential hypertension, and efficacy has been demonstrated for up to 48 weeks. The frequency of adverse clinical effects was similar in all three treatment groups, and serious adverse clinical effects were rare.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6100881

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN： 0952-1178


  9 in total

1.  [Surveillance and assessment of undesirable effects in drug treatment: pilot project].

Authors:  M Hannig; R Hanpft
Journal:  Soz Praventivmed       Date:  1989

Review 2.  ACE inhibitors compared with thiazide diuretics as first-step antihypertensive therapy.

Authors:  I J Perry; D G Beevers
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

Review 3.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 4.  ACE inhibitors. Drug interactions of clinical significance.

Authors:  C Mignat; T Unger
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 5.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

7.  Enalapril and hydrochlorothiazide in hypertensive Africans.

Authors:  A A Ajayi; E A Oyewo; G O Ladipo; A Akinsola
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 8.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 9.  Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.

Authors:  Gianpaolo Reboldi; Giorgio Gentile; Fabio Angeli; Paolo Verdecchia
Journal:  Vasc Health Risk Manag       Date:  2009
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.